Junker K, Becker C, Wullich B
Klinik für Urologie, Universitätsklinikum Jena, Friedrich-Schiller-Universität, Lessingstraße 1, 07743 Jena, Deutschland.
Urologe A. 2011 Aug;50(8):932-7. doi: 10.1007/s00120-011-2544-4.
Research is more important than ever for urology as a clinical specialty. The enormous advances being achieved in molecular medicine should not develop outside the realm of urology. In fact, implementing them in urology serves to guarantee the further existence of our specialty with its current clinical scope. If drug therapy for cancer is to remain an enduring part of urology or if kidney transplantation is to continue to be an integral part of urology and not belong to transplant surgery, then the expertise in these clinical entities and understanding of their pathogenetic relationships must be found in urology. As a result, research must be an essential part of our specialty on the one hand and the results of research must be applied to the whole extent of urology on the other hand.
作为一门临床专科,研究对泌尿外科而言比以往任何时候都更为重要。分子医学正在取得的巨大进展不应脱离泌尿外科领域而发展。事实上,在泌尿外科应用这些进展有助于确保我们这一专科在当前临床范围内的持续存在。如果癌症药物治疗要继续作为泌尿外科的一个持久组成部分,或者如果肾脏移植要继续作为泌尿外科不可或缺的一部分而不属于移植外科,那么在泌尿外科必须具备这些临床实体方面的专业知识并了解其发病机制关系。因此,一方面研究必须是我们这一专科的重要组成部分,另一方面研究结果必须在泌尿外科的整个范围内得到应用。